Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | 10-K | snti-20241231.htm iXBRL | 10-K | 3085685 |
2 | DESCRIPTION OF SECURITIES | a2024123110kex43.htm | EX-4.3 | 52191 |
3 | FORM OF PSU | a2024123110kex1042.htm | EX-10.42 | 56325 |
4 | GENEFAB A&R DMSA | a2024123110kex1043.htm | EX-10.43 | 539057 |
5 | GENEFAB FRAMEWORK AGREEMENT AMENDMENT | a2024123110kex1044.htm | EX-10.44 | 1538411 |
6 | GENEFAB OPTION AGREEMENT AMENDMENT | a2024123110kex1045.htm | EX-10.45 | 21350 |
7 | INSIDER TRADING POLICY | a2024-13x3110kex191.htm | EX-19.1 | 110961 |
8 | CONSENT | a2024123110kex231.htm | EX-23.1 | 2069 |
9 | CERTIFICATION | a2024123110kex311.htm | EX-31.1 | 11516 |
10 | CERTIFICATION | a2024123110kex321.htm | EX-32.1 | 5675 |
16 | image_0.jpg | GRAPHIC | 91521 | |
17 | image_0a.jpg | GRAPHIC | 25048 | |
18 | image_1.jpg | GRAPHIC | 1248 | |
19 | image_10.jpg | GRAPHIC | 473 | |
20 | image_2.jpg | GRAPHIC | 84561 | |
21 | image_2a.jpg | GRAPHIC | 2251 | |
22 | image_3.jpg | GRAPHIC | 129871 | |
23 | image_3a.jpg | GRAPHIC | 456 | |
24 | image_4.jpg | GRAPHIC | 177741 | |
25 | image_4a.jpg | GRAPHIC | 443 | |
26 | image_5.jpg | GRAPHIC | 92571 | |
27 | image_5a.jpg | GRAPHIC | 707 | |
28 | image_6.jpg | GRAPHIC | 29513 | |
29 | image_6a.jpg | GRAPHIC | 873 | |
30 | image_7.jpg | GRAPHIC | 693 | |
31 | image_8.jpg | GRAPHIC | 458 | |
32 | image_9.jpg | GRAPHIC | 392 | |
33 | snti-20241231_g1.jpg | GRAPHIC | 31108 | |
34 | snti-20241231_g10.jpg | GRAPHIC | 3859 | |
35 | snti-20241231_g11.jpg | GRAPHIC | 3799 | |
36 | snti-20241231_g12.jpg | GRAPHIC | 3788 | |
37 | snti-20241231_g13.jpg | GRAPHIC | 4051 | |
38 | snti-20241231_g14.jpg | GRAPHIC | 3478 | |
39 | snti-20241231_g15.jpg | GRAPHIC | 45660 | |
40 | snti-20241231_g16.jpg | GRAPHIC | 44540 | |
41 | snti-20241231_g17.jpg | GRAPHIC | 49457 | |
42 | snti-20241231_g2.jpg | GRAPHIC | 51685 | |
43 | snti-20241231_g3.jpg | GRAPHIC | 25981 | |
44 | snti-20241231_g4.jpg | GRAPHIC | 24710 | |
45 | snti-20241231_g5.jpg | GRAPHIC | 22722 | |
46 | snti-20241231_g6.jpg | GRAPHIC | 155721 | |
47 | snti-20241231_g7.jpg | GRAPHIC | 40828 | |
48 | snti-20241231_g8.jpg | GRAPHIC | 46063 | |
49 | snti-20241231_g9.jpg | GRAPHIC | 3615 | |
Complete submission text file | 0001854270-25-000042.txt | 17529094 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | snti-20241231.xsd | EX-101.SCH | 82724 |
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | snti-20241231_cal.xml | EX-101.CAL | 99295 |
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | snti-20241231_def.xml | EX-101.DEF | 568513 |
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | snti-20241231_lab.xml | EX-101.LAB | 997688 |
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | snti-20241231_pre.xml | EX-101.PRE | 783560 |
144 | EXTRACTED XBRL INSTANCE DOCUMENT | snti-20241231_htm.xml | XML | 1401802 |
EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40440 | Film No.: 25757381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)